Press Events

Understanding the genetic makeup of complex chronic diseases is a significant step toward developing advanced diagnostics and better treatment options. In that vein, an international team of investigators led by scientists at the University of Manchester put together an extensive genome-wide association study (GWAS) to identify the genetic factors that predispose people to chronic kidneyRead more

Researchers at the University of Minnesota have developed a technique to stop cancer cells from moving and metastasizing. The discovery could have a major impact on millions of people undergoing therapies to prevent the spread of cancer within the body, according to the scientists.   It’s been known for years that tumors have patterns thatRead more

The tiny Teste fly has been a scourge for centuries in many parts of Africa, spreading the debilitating and even deadly disease called African sleeping sickness. Now, investigators from Clemson University have released new findings focusing on the biological cues that signal the parasite which causes the disease – Trypanosoma brucei – to change lifeRead more

Epigenetic regulators that modify factors involved in switching genes on and off represent attractive anticancer targets, but whether this strategy will work in vivo hasn’t yet been proven. Studies in mice by researchers headed by a Boston Children’s Hospital team now suggest that blocking one epigenetic regulator – a histone methyltransferase known as G9a –Read more

The battle between medicine and harmful bacteria has traditionally centered on the hunt for new antimicrobial drugs, but the pathogens almost inevitably develop resistance to every type of antibiotic developed. A team at the University of Washington (UW), Seattle, has now developed a new strategy that thwarts this ability to develop antimicrobial drug resistance (AMR)Read more